Analysis of tissue and serum microrna expression in patients with upper urinary tract urothelial cancer

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Kriebel, Stephanie ^a   Schmidt, Doris ^a   Holdenrieder, Stefan ^a   Goltz, Diane ^a   Kristiansen, Glen ^a   Moritz, Rudolf ^b   Fisang, Christian ^a   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 10A; MICRORNA 1244; MICRORNA 135; MICRORNA 141; MICRORNA 182; MICRORNA 200B; MICRORNA 205; MICRORNA 21; MICRORNA 429; MICRORNA 520B; MICRORNA 96; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEPHROURETERECTOMY; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; TISSUE DIFFERENTIATION; UPPER URINARY TRACT UROTHELIAL CANCER; UPREGULATION; URINARY TRACT CANCER; BLOOD; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSITIONAL CELL CARCINOMA; URINARY TRACT; URINARY TRACT TUMOR; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, TRANSITIONAL CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; UP-REGULATION; URINARY TRACT; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84922164981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117284     Document Type: Article

References (40)

1. Ploeg M, Aben KK, Kiemeney LA (2009) The present and future burden of urinary bladder cancer in the world. World J Urol 27: 289-293. doi: 10.1007/s00345-009-0383-3 PMID: 19219610
2. Verhoest G, Shariat SF, Chromecki TF, Raman JD, Margulis V, et al. (2011) Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol 29: 495-501. doi: 10.1007/ s00345-011-0710-3 PMID: 21681525
3. Dietrich D, Meller S, Uhl B, Ralla B, Stephan C, et al. (2014) Nucleic acid-based tissue biomarkers of urologic malignancies. Crit Rev Clin Lab Sci: 1-27. doi: 10.3109/10408363.2014.950407 PMID: 25547534
4. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in Human Cancer. Adv Exp Med Biol 774: 1-20. doi: 10.1007/978-94-007-5590-1-1 PMID: 23377965
5. Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, et al. (2014) New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney. PLoS One 9: e91646. doi: 10.1371/journal.pone.0091646 PMID: 24621579
6. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741. doi: 10.1373/clinchem.2010.147405 PMID: 20847327
7. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006. doi: 10.1038/cr. 2008.282 PMID: 18766170
8. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, et al. (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54: 482-490. doi: 10.1373/clinchem.2007.097972 PMID: 18218722
9. Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, et al. (2012) Circulating micro-RNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol. doi: 10.1007/s00345-012-1015-x PMID: 23274528
10. Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, et al. (2011) MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. PLoS One 6: e25787. doi: 10.1371/journal. pone.0025787 PMID: 21984948
11. Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Muller SC, et al. (2011) Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology 77: 1265 e1269-1216.
12. Dieckmann KP, Spiekermann M, Balks T, Flor I, Loning T, et al. (2012) MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107: 1754-1760. doi: 10.1038/bjc.2012.469 PMID: 23059743
13. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392. PMID: 17826655
14. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6: e18286. doi: 10.1371/journal.pone.0018286 PMID: 21464941
15. Li X, Chen J, Hu X, Huang Y, Li Z, et al. (2011) Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One 6: e22570. doi: 10.1371/journal.pone.0022570 PMID: 21799901
16. Song T, Xia W, Shao N, Zhang X, Wang C, et al. (2010) Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev 11: 905-911. PMID: 21133599
17. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860. doi: 10.1158/0008-5472.CAN-08-4043 PMID: 19487295
18. Catto JW, Miah S, Owen HC, Bryant H, Myers K, et al. (2009) Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 69: 8472-8481. doi: 10.1158/0008-5472.CAN-09-0744 PMID: 19843843
19. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, et al. (2013) microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer 132: 2479-2491. doi: 10.1002/ijc.27949 PMID: 23169479
20. Zaravinos A, Radojicic J, Lambrou GI, Volanis D, Delakas D, et al. (2012) Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer. J Urol 188: 615-623. doi: 10.1016/j.juro.2012. 03.122 PMID: 22704449
21. Sanders I, Holdenrieder S, Walgenbach-Brunagel G, von Ruecker A, Kristiansen G, et al. (2012) Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol 19: 1017-1025. doi: 10.1111/j.1442-2042.2012.03082.x PMID: 22788411
22. Izquierdo L, Ingelmo-Torres M, Mallofre C, Lozano JJ, Verhasselt-Crinquette M, et al. (2013) Prognostic Value Of Microrna Expression Pattern In Upper Tract Urothelial Carcinoma. BJU Int. doi: 10.1111/bju.12334 PMID: 24717097
23. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176. doi: 10.1002/ijc. 24827 PMID: 19676045
24. Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, et al. (2014) Serum microRNAs as Biomarkers in Patients Undergoing Prostate Biopsy: Results from a Prospective Multi-Center Study. Anticancer Res 34: 665-669. PMID: 24510997
25. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, et al. (2011) Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128: 608-616. doi: 10.1002/ijc.25376 PMID: 20473869
26. Selth LA, Townley SL, Bert AG, Stricker PD, Sutherland PD, et al. (2013) Circulating microRNAs predict biochemical recurrence in prostate cancer patients. Br J Cancer 109: 641-650. doi: 10.1038/bjc.2013.369 PMID: 23846169
27. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, et al. (2012) Changes in circulating micro-RNA levels associated with prostate cancer. Br J Cancer 106: 768-774. doi: 10.1038/bjc.2011.595 PMID: 22240788
28. Wang G, Chan ES, Kwan BC, Li PK, Yip SK, et al. (2012) Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 10: 106-113. doi: 10.1016/j.clgc.2012.01.001 PMID: 22386240
29. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, et al. (2011) Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6: e17745. doi: 10. 1371/journal.pone.0017745 PMID: 21445232
30. Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, et al. (2014) Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol 7: 6. doi: 10.1186/1756-8722-7-6 PMID: 24405714
31. van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, et al. (2013) miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 32: 4284-4293. doi: 10.1038/onc.2012.433 PMID: 23045278
32. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-229. doi: 10.1093/nar/gkr1161 PMID: 22135297
33. Zhang L, Deng T, Li X, Liu H, Zhou H, et al. (2010) microRNA-141 is involved in a nasopharyngeal car-cinoma-related genes network. Carcinogenesis 31: 559-566. doi: 10.1093/carcin/bgp335 PMID: 20053927
34. Hyun S, Lee JH, Jin H, Nam J, Namkoong B, et al. (2009) Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K. Cell 139: 1096-1108. doi: 10.1016/j.cell.2009.11. 020 PMID: 20005803
35. Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, et al. (2013) miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. J Mol Diagn 15: 695-705. doi: 10.1016/ j.jmoldx.2013.05.008 PMID: 23945108
36. Dip N, Reis ST, Timoszczuk LS, Viana NI, Piantino CB, et al. (2012) Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile. J Urol 188: 1951-1956. doi: 10. 1016/j.juro.2012.07.004 PMID: 22999546
37. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi: 10.1073/ pnas.0804549105 PMID: 18663219
38. Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, et al. (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108: 701-705. doi: 10.1111/j.1464-410X.2010.09899.x PMID: 21320275
39. Walsh IK, Keane PF, Ishak LM, Flessland KA (2001) The BTA stat test: a tumor marker for the detection of upper tract transitional cell carcinoma. Urology 58: 532-535. PMID: 11597532
40. Johannes JR, Nelson E, Bibbo M, Bagley DH (2010) Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance. J Urol 184: 879-882. doi: 10.1016/j.juro.2010. 05.023 PMID: 20643443